Is FPRX A Good Stock To Buy Now?
Is Five Prime Therapeutics Inc (NASDAQ:FPRX) a good place to invest some of your money right now? We can gain invaluable insight to help us answer that question by studying the...
Posts Tagged ‘NASDAQ:FPRX’
Hedge Funds Are Coming Back To Five Prime Therapeutics Inc (FPRX)
Insider Monkey has processed numerous 13F filings of hedge funds and successful value investors to create an extensive database of hedge fund holdings.
Is Five Prime Therapeutics Inc (FPRX) Going to Burn These Hedge Funds?
The latest 13F reporting period has come and gone, and Insider Monkey is again at the forefront when it comes to making use of this gold mine of data.
Is Five Prime Therapeutics Inc (FPRX) A Good Stock To Buy ?
Concerns over rising interest rates and expected further rate increases have hit several stocks hard during the fourth quarter of 2018.
Is Five Prime Therapeutics Inc (FPRX) A Good Stock To Buy?
Although the masses and most of the financial media blame hedge funds for their exorbitant fee structure and disappointing performance, these investors have proved to have great...
Cabiralizumab From Five Prime Therapeutics Inc (FPRX) Obtains Orphan Designation
The European Commission has certified orphan designation for cabiralizumab.
Bristol-Myers Squibb Co (BMY) Agrees To Extend Research With Five Prime Therapeutics Inc (FPRX)
Bristol-Myers Squibb Co (NYSE:BMY) has opted to extend the research term of its discovery collaboration agreement with Five Prime Therapeutics Inc (NASDAQ:FPRX).
Is Five Prime Therapeutics Inc (FPRX) A Good Stock To Buy?
It is already common knowledge that individual investors do not usually have the necessary resources and abilities to properly research an investment opportunity.
Why Do Hedge Funds Like Five Prime Therapeutics?
Five Prime Therapeutics Inc (NASDAQ:FPRX) is a $1.25 billion biotech company that focuses on the discovery and development of protein therapeutics that block cancer and inflammatory...
Battered Performance Sports Group Ltd (PSG) and Two Strong-Performing Companies Witness Insider Buying
According to fresh data from CNBC, the dollar value of all insider purchases in April has been the lowest in the past 11 months or so.
Why Are These Stocks Surging Today?
It's Thursday and shareholders of BofI Holding, Inc.
Has Five Prime Therapeutics Inc. (FPRX) Turned The Corner? Adage Capital Thinks So
Adage Capital Management, founded by Phill Gross and Robert Atchinson, recently disclosed an ownership stake of 2.66 million shares in Five Prime Therapeutics Inc.
Zeltiq Aesthetics Inc (ZLTQ), Five Prime Therapeutics Inc (FPRX): Point72’s Latest Bullish Moves
Steve Cohen’s Point72 Asset Management has made bullish moves into a pair of medical technology stocks.
Adage Capital Management Ups Stake in Five Prime Therapeutics Inc (FPRX)
In a new filing with the U.S.
Healthcor Management Reduces Position in Allscripts Healthcare Solutions Inc (MDRX)
Arthur Cohen and Joseph Healey's Healthcor Management, revealed, in a newly amended filing with the SEC, decreasing its holding in Allscripts Healthcare Solutions Inc (NASDAQ:...
Healthcor Management Reveals New Passive Stake in Five Prime Therapeutics
Arthur Cohen and Joseph Healey's Healthcor Management has added Five Prime Therapeutics Inc (NASDAQ:FPRX) to its equity portfolio, a new filing with the SEC revealed.
